Somewhere between a doctor typing a note and another doctor reading it at a different health system, the note has to survive a journey through incompatible software. Trip Hofer's company is what carries it.
Redox is the kind of company you only notice when it fails, which is to say most people never notice it at all. It sits between digital-health applications and electronic medical records, reading data out and writing data back in, so that a startup building, say, a remote-monitoring tool does not have to individually negotiate with every hospital's records system. In 2024 that middle layer processed more than 15 billion healthcare data transactions across more than 12,000 organizations and 90-plus EHRs. Hofer took over as CEO in November 2023, and the business of the company is, essentially, that the number keeps going up and nothing breaks.
His pitch is unusually blunt for a category that loves buzzwords. Everyone in healthcare wants to bolt AI onto their operations. Hofer's position is that they are skipping a step. "Without proper data interoperability, there is no useful AI or machine learning in healthcare. Full stop." The model can be brilliant; if it cannot get clean, complete data at the moment a clinician needs it, it is a demo. Redox exists to make the boring precondition true.
Without proper data interoperability, there is no useful AI or machine learning in healthcare. Full stop.
The interesting thing about Hofer's diagnosis is where he locates the difficulty. The industry spent years treating the problem as a format problem - if everyone would just adopt FHIR, the standard for health-data exchange, records would flow. Hofer agrees the format helps. But he keeps redirecting the conversation to workflow. Getting data from point A to point B in healthcare is hard because the data is messy and the processes around it are complicated. A standard format is a shared alphabet; it does not, on its own, teach two organizations to have a conversation. Redox describes itself as a technology company with services - people who sit with each client and make the integration actually fit how they work.
A career spent on the seams
Hofer has been circling this problem for a long time, and from a lot of angles. He describes the throughline of his career as a recurring frustration: "What seemed simple verbally and logically got complex and became undoable. That was always frustrating when trying to serve patients better." That is the emotional core of a healthcare-infrastructure career - watching obviously good ideas die in the gap between systems.
He did not start in healthcare. He began as a management consultant at Booz Allen, then took senior roles supporting the Office of the Mayor of Washington, D.C. He moved into the health sector around 2002 and stayed. There were leadership roles at UnitedHealth Group and Health Dialog. At CVS Health he ran acquired businesses - Accordant and Novologix - the unglamorous work of making a purchase actually function inside a giant company.
Then came the chapter that defines him to most people who know his name. He led AbleTo, a virtual mental-health provider, and led its sale to Optum in 2020. Afterward he became CEO of Optum Behavioral Solutions, described as the largest provider of mental-health services in the United States. He went, in other words, from selling a company into a giant to running one of that giant's largest divisions - a useful education in both the startup and the incumbent side of American healthcare.
"Healthcare organizations in the provider and payer space rely on workflows that are very complicated."
"Transparent, humble, and well-versed on the healthcare ecosystem." - how he describes himself.
The handoff
Redox was founded and led by Luke Bonney, a co-founder who, in 2023, decided the company's next phase needed a CEO with experience scaling organizations - and who cited family reasons for stepping back. This is the moment that usually gets messy at venture-backed startups. Here it did not. Bonney moved to an advisory role, Hofer took the seat in November 2023, and the transactions kept flowing. For a company whose entire value proposition is reliability, a drama-free succession is almost thematically appropriate.
Hofer arrived with a second hat already on. In 2023 he also joined .406 Ventures as a Venture Partner, where he advises portfolio companies across health tech - Redox among them, alongside businesses in youth performance psychology and virtual cardiovascular care. It is a arrangement that lets him see the interoperability problem from the investor's side of the table and the operator's side at the same time.
Empathy as an operating model
For a person who runs a data-plumbing company, Hofer talks a surprising amount about empathy. His stated philosophy leans on understanding each stakeholder's actual problem before designing a strategy - which, in a field full of technically correct solutions that nobody can use, is less soft than it sounds. He speaks admiringly of other operators in the space as people with "a unique drive to impact and effect real change," the kind of person who, when you talk to them, clearly knows more than most. It is the language of someone who has spent 25 years learning that the hard part of healthcare is rarely the technology.
Hofer discussed why healthcare cannot afford to wait on interoperability on the Diagnosing Healthtech series: